Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents

Blood

Volumn 94, Issue 4, 1999, Pages 1359-1371

  Koski, Gary K ^b   Schwartz, Gretchen N ^b   Weng, David E ^b   Gress, Ronald E ^b   Engels, Friederike H C ^b   Tsokos, Maria ^b   Czerniecki, Brian J ^b   Cohen, Peter A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; CD83 ANTIGEN; CD86 ANTIGEN;

ARTICLE; CALCIUM MOBILIZATION; CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HL 60; CELL TRANSFORMATION; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033566626     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1359     Document Type: Article

References (57)

1. Lim SH, Coleman S: Chronic myeloid leukemia as an immunological target. Am J Hematol 54:61, 1997
2. Santiago-Schwarz F, Coppock DL, Hindenburg AA, Kern J: Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84:3054, 1994
3. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101, 1997
4. Munro JM, Freedman AS, Aster JC, Gribben JG, Lee NC, Rhynhart KK, Banchereau J, Nadler LM: In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease. Blood 83:793, 1994
5. Hirano N, Takahashi T, Ohtake S, Hirashima K, Emi N, Saito K, Hirano M, Shinohara K, Takeuchi M, Taketazu F, Tsunoda S, Ogura M, Omine M, Saito T, Yazaki Y, Ueda R, Hirai H: Expression of costimulatory molecules in human leukemias. Leukemia 10:1168, 1996
6. Tsukada N, Aoki S, Maruyama S, Kishi K, Takahashi M, Aizawa Y: The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon. J Exp Clin Cancer Res 16:171, 1997
7. Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM: Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88:41, 1996
8. Schultze JL, Cardoso AA, Freeman GJ, Seamon MJ, Daley J, Pinkus GS, Gribben JG, Nadler LM: Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity (published erratum appears in Proc Natl Acad Sci USA 92:10818, 1995). Proc Natl Acad Sci USA 92:8200, 1995
9. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903, 1995
10. Smit WM, Rijnbeek M, van Bergen CA, de Paus RA, Vervenne HA, van de Keur M, Willemze R, Falkenburg JH: Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 53:216, 1997
11. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreeff M, Champlin RE: Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89: 1133, 1997
12. Caux C, Burdin N, Galibert L, Hermann P, Renard N, Servet-Delprat C, Banchereau J: Functional CD40 on B lymphocytes and dendritic cells. Res Immunol 145:235, 1994
13. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263, 1994
14. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 185:341, 1997
15. Matulonis UA, Dosiou C, Lamont C, Freeman GJ, Mauch P, Nadlet LM, Griffin JD: Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85:2507, 1995
16. Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ: Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. Blood 87:2938, 1996
17. Hirano N, Takahashi T, Azuma M, Okumura K, Yazaki Y, Yagita H, Hirai H: Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells. Hum Gene Ther 8:1375, 1997
18. Czerniecki BJ, Carter C, Rivoltini L, Koski GK, Kim HI, Weng DE, Rorors JG, Hijazi YM, Shuwen X, Rosenberg SA, Cohen PA: Calcium ionophore treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159:3823, 1997
19. + dendritic cells. Proc Natl Acad Sci USA 93:2588, 1996
20. Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA, Steinman RM, Young JW: Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87:4520, 1996
21. Lardon F, Snoeck HW, Berneman ZN, Van Tendeloo VF, Nijs G, Lenjou M, Henckaerts E, Boeckxtaens CJ, Vandenabeele P, Kestens LL, VanBockstaele DR, Vanham GL: Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: Antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology 91:553, 1997
22. Schwartz GN: Use of gel-well culture chambers as a liquid culture system to measure responses of hematopoietic colony-forming cells to growth factors. Int J Cell Cloning 7:360, 1989
23. + T cell lines from naive precursors. Eur J Immunol 25:1206, 1995
24. Kataoka A, Kubota M, Wakazono Y, Okuda A, Bessho R, Lin YW, Usami I, Akiyama Y, Furusho K: Association of high molecular weight DNA fragmentation with apoptotic or non-apoptotic cell death induced by calcium ionophore. FEBS Lett 364:264, 1995
25. Naora H: Differential expression patterns of beta-actin mRNA in cells undergoing apoptosis. Biochem Biophys Res Commun 211:491, 1995
26. Triozzi PL, Aldrich W: Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages. J Leukoc Biol 61:600, 1997
27. Peters JH, Xu H, Ruppert J, Ostermeier D, Friedrichs D, Gieseler RK: Signals required for differentiating dendritic cells from human monocytes in vitro. Adv Exp Med Biol 329:275, 1993
28. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 59:208, 1996
29. + peripheral blood monocytes. J Immunol 157:3850, 1996
30. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
31. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994
32. Steeg PS, Sztein MB, Mann DL, Strong DM, Oppenheim JJ: Interferon regulation of DR antigen expression and alloantigen-presenting capabilities of the promyelocytic cell line HL60. Scand J Immunol 21:425, 1985
33. Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347, 1977
34. Collins SJ: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233, 1987
35. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC: Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75:2458, 1978
36. Geary SM, Ashman LK: HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: Analysis of the responding population and mechanism of cytotoxic lymphocyte activation. Immunology 88:428, 1996
37. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y, Suda T: 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102:937, 1981
38. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T: 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J 204:713, 1982
39. McCarthy DM, San Miguel JF, Freake HC, Green PM, Zola H, Catovsky D, Goldman JM: 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res 7:51, 1983
40. Ball ED, Guyre PM, Shen L, Glynn JM, Maliszewski CR, Baker PE, Fanger MW: Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest 73:1072, 1984
41. Rovera G, Santoli D, Damsky C: Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779, 1979
42. Fischkoff SA, Pollak A, Gleich GJ, Testa JR, Misawa S, Reber TJ: Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med 160:179, 1984
43. Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantu-Rajnoldi A, Biondi A, Cocito MG, Del Vecchio L, Tabilio A, Avvisati G, Basso G, Lo Coco F: Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 102:1035, 1998
44. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PJ: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108, 1995
45. Stone, RM, Mayer RJ: The unique aspects of acute promyelocytic leukemia. J Clin Oncol 8:1913, 1990
46. Saji M, Shong M, Napolitano G, Palmer LA, Taniguchi SI, Ohmori M, Ohta M, Suzuki K, Kirshner SL, Giuliani C, Singer DS, Kohn LD: Regulation of major histocompatibility complex class I gene expression in thyroid cells. Role of the cAMP response element-like sequence. J Biol Chem 272:20096, 1997
47. Rotem-Yehudar R, Winograd S, Sela S, Coligan JE, Ehrlich R: Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J Exp Med 180:477, 1994
48. ++)-dependent, FK506-sensitive pathway. Eur J Immunol 24:3229, 1994
49. Finney M, Guy GR, Michell RH, Gordon J, Dugas B, Rigley KP, Callard RE: Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. Eur J Immunol 20:151, 1990
50. Koski GK, Schwartz GN, Weng DE, Czerniecki BJ, Carter C, Gress RE, Cohen PA: Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J Immunol (in press)
51. Lauener RP, Goyert SM, Geha RS, Vercelli D: Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 20:2375, 1990
52. Ruppert J, Friedrichs D, Xu H, Peters JH: IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 182:449, 1991
53. Ruppert J, Schutt C, Ostermeier D, Peters JH: Down-regulation and release of CD14 on human monocytes by IL-4 depends on the presence of serum or GM-CSF. Adv Exp Med Biol 329:281, 1993
54. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
55. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52:274, 1992
56. + progenitors in human bone marrow. J Immunol 149:2681, 1992
57. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 154:5851, 1995